POLYNOMA

Polynoma is an immuno-oncology company developing seviprotimut-L, a novel polyvalent shed antigens vaccine for the adjuvant treatment of melanoma. Melanoma cells are grown in bioreactors and cellular and melanoma-associated proteins are shed under optimized conditions, collected and then partially purified to separate them from non-essential whole cell and nuclear material, thereby minimizing extraneous cell components — concentrating the amount of antigens relevant to melanoma.